Genomic and immune characteristics of <i>HER2</i>‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapyHai‐Yan Tu, Yi‐Long Wu, E‐E Ke et al.|Molecular Oncology|2023Cited by 9
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort studyXiao‐Feng Le, Ke Pan, Fangdi Sun et al.|Annals of Oncology|2025Cited by 9